A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer
| Image |  |
|---|---|
| Description | scientific article published on 13 June 2015 |
| Author/s |
author: John D Hainsworth Celestia Higano |
| Publication date | June 13, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |